回复：胃泌素释放肽拮抗剂对实验性良性前列腺增生的缩小作用及前列腺细胞体积的减小 - Suppr | 超能文献

Re: Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

作者信息

Atala Anthony

出版信息

J Urol. 2013 Oct;190(4):1436. doi: 10.1016/j.juro.2013.06.055. Epub 2013 Jun 26.

DOI:10.1016/j.juro.2013.06.055

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.回复：胃泌素释放肽拮抗剂对实验性良性前列腺增生的缩小作用及前列腺细胞体积的减小

J Urol. 2013 Oct;190(4):1436. doi: 10.1016/j.juro.2013.06.055. Epub 2013 Jun 26.

2

Re: Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing Peptide antagonist.回复：胃泌素释放肽拮抗剂对实验性良性前列腺增生的缩小作用及前列腺细胞体积的减小

J Urol. 2013 Nov;190(5):1956. doi: 10.1016/j.juro.2013.07.046. Epub 2013 Jul 26.

3

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.胃泌素释放肽拮抗剂缩小实验性良性前列腺增生和减少前列腺细胞体积。

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2617-22. doi: 10.1073/pnas.1222355110. Epub 2013 Jan 28.

4

Gastrin-releasing peptide: an identity crisis at 30?胃泌素释放肽：30 岁时的身份危机？

Lancet. 2001 Sep 8;358(9284):778-9. doi: 10.1016/s0140-6736(01)06008-1.

5

Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.生长激素释放激素（GHRH）拮抗剂以及蛙皮素/胃泌素释放肽（BN/GRP）拮抗剂可抑制PC-3和DU-145人雄激素非依赖性前列腺癌中血管内皮生长因子（VEGF）、碱性成纤维细胞生长因子（bFGF）以及表皮生长因子/人表皮生长因子受体（EGF/HER）家族受体的表达。

Prostate. 2005 Aug 1;64(3):303-15. doi: 10.1002/pros.20262.

6

Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.联合使用生长激素释放激素拮抗剂和黄体生成素释放激素拮抗剂可显著增强良性前列腺增生的缩小。

J Urol. 2012 Apr;187(4):1498-504. doi: 10.1016/j.juro.2011.11.081. Epub 2012 Feb 17.

7

Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.蛙皮素/胃泌素释放肽拮抗剂对裸鼠人恶性胶质母细胞瘤生长的抑制作用

Oncogene. 1999 Nov 25;18(50):7168-73. doi: 10.1038/sj.onc.1203213.

8

Regulation of gastric function by gastrin releasing peptide.胃泌素释放肽对胃功能的调节

Gut. 2002 Jun;50(6):897-8; author reply 898. doi: 10.1136/gut.50.6.897-a.

9

Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.生长抑素类似物RC - 160和蛙皮素/胃泌素释放肽拮抗剂RC - 3095对雄激素非依赖性邓宁R - 3327 - AT - 1大鼠前列腺癌生长的抑制作用

Cancer Res. 1994 Jan 1;54(1):169-74.

10

Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.**RC-3940-II**，一种蛙皮素/胃泌素释放肽拮抗剂，强力抑制实验性肝癌的体内生长。

Anticancer Drugs. 2012 Oct;23(9):906-13. doi: 10.1097/CAD.0b013e328354bd25.